• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Are Thyroid Test Abnormalities a Risk Factor for Preterm Birth?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Korevaar et al. (JAMA, 2019) investigated whether maternal thyroid function test levels associated with non-overt, milder thyroid abnormalities and thyroid autoimmunity are risk factors for preterm birth

METHODS:

  • Systematic review and meta-analysis
    • Study conducted by the Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth (collaboration of prospective birth cohorts)
    • Individual data was collected so that definitions for thyroid test levels could be standardized
  • Data sources
    • Published data: Ovid MEDLINE, EMBASE, Web of Science, the Cochrane Central Register of Controlled Trials, and Google Scholar databases
    • Unpublished data: Open invitations sent to relevant journals, international conferences, social media, and personal contacts
  • Inclusion criteria
    • Published and unpublished prospective cohort studies
    • Studies with data on relevant thyroid function tests
      • Thyrotropin (TSH) | Free thyroxine (FT4) | thyroid peroxidase (TPO) antibody
    • Exclusion: Studies only including overt thyroid disease or treatment was administered based on abnormal thyroid function tests
  • Definitions:
    • Subclinical hypothyroidism: Increased thyrotropin concentration with normal FT4 concentration
    • Isolated hypothyroxinemia: Decreased FT4 concentration with normal thyrotropin concentration
  • Data synthesis and analysis
    • Studies screened by 2 independent reviewers
    • Individual participant data were analyzed using mixed-effects models
    • Adjustments made for: Maternal age | BMI | Ethnicity | Smoking | Parity | Gestational age at blood sampling | Fetal sex
  • Primary outcome: Preterm birth (<37 weeks)
  • Secondary outcome: Very preterm birth (<32 weeks)

RESULTS:

  • 19 cohorts were included | 47,045 pregnant women | 5.0% preterm birth   
    • Subclinical hypothyroidism: 3.1%
    • Isolated hypothyroxinemia: 2.2%
    • TPO antibody positive: 7.5%
  • Risk of preterm birth was higher for subclinical hypothyroidism (6.1%) vs euthyroid (5.0%)
    • Odds ratio (OR) 1.29 (95% CI, 1.01 to 1.64)
  • Risk of preterm birth was higher for isolated hypothyroxinemia (7.1%) vs euthyroid (5.0%)
    • OR 1.46 (95% CI, 1.12 to 1.90)
    • Risk also increased for very preterm birth (OR 2.57; 95% CI, 1.55 to 4.27)
  • Each 1-SD higher maternal TSH concentration was associated with a higher risk of preterm birth
    • Absolute risk difference 0.2% (95% CI, 0% to 0.4%) per 1 SD
    • OR 1.04 (95% CI, 1.00 to 1.09) per 1 SD
  • TPO antibody–positive had a higher risk of preterm birth vs TPO antibody–negative
    • Absolute risk difference 1.6% (95% CI, 0.7% to 2.8%)
    • OR 1.33 (95% CI, 1.15 to 1.56)
    • Risk was also increased for very preterm birth (OR 2.45; 95% CI, 1.81 to 3.32)

CONCLUSION:

  • Subclinical hypothyroidism, isolated hypothyroxinemia, and TPO antibody positivity were associated with a higher risk of preterm birth
  • Authors suggest that while these results do not support universal thyroid screening in pregnancy

The results support the concept of a reflex TPO antibody measurement in women with a thyrotropin concentration higher than 4.0 mIU/L, and gestational thyrotropin monitoring for TPO antibody–positive women prior to conception.

  • An accompanying editorial (see ‘Learn More – Primary Sources’) points out that routine screening for TSH, free thyroxine and TPO antibody is not recommended by ACOG or the American Thyroid Association based on previous RCTs and further states

Several recent large, well-done clinical trials that assessed the effect of routine pregnancy screening for and thyroid hormone treatment of subclinical hypothyroidism, isolated hypothyroxinemia, and TPO antibody positivity have failed to show benefit. It seems plausible that these thyroid testing abnormalities may reflect other nonthyroidal processes rather than thyroid dysfunction.

Learn More – Primary Sources:

Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis

Editorial: Thyroid Function Test Abnormalities During Pregnancy

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Subclinical Hypothyroidism and Pregnancy Outcome – Is There a Relationship?
Does Levothyroxine Increase Live Birth Rate in Women with Thyroid Peroxidase Antibodies?
Should Levothyroxine be Used to Treat Subclinical Hypothyroidism?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site